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TO THE EDITOR, 
In 2010 we reported two separate homozygous mutations in the 5’ region of JUP which 
segregated with skin fragility and normal heart development in children from four separate 
families(1). At the time, only 3 mutations in this gene had been previously reported and each of 
the earlier identified mutations segregated with an inherited progressive disease of the heart, 
arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)(2-4). Five years on and 
as a result of close monitoring in each patient we report here that the eldest individual harboring 
homozygous mutations p.S24X has been diagnosed with left dilated cardiomyopathy (also 
considered ARVD/C) at age 17 years. All other patients examined report normal heart function. 
 
The JUP gene encodes the protein plakoglobin (PG), also known as -catenin, which is abundant 
in cell cell junction complexes of adherens junctions and desmosomes. As well as this structural 
role PG can also influence cellular signaling where it’s homology to and interaction with, -
catenin is crucial (for review see(5)). Mutations in JUP leading to Naxos disease(3), a so-called 
cardio-cutaneous syndrome affecting both skin and heart, identified PG as a protein important in 
these tissues, and confirmed earlier observations that mutation in genes encoding desmosomal 
components are a major cause of this type of cardiomyopathy(6). While originally termed 
ARVD/C, it has been shown that both right and left ventricles are often affected and as such, a 
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descriptive change to Arrhythmogenic Cardiomyopathy (AC) has been proposed to better reflect 
the pathology(7). Nearly half of all diagnosed AC patients harbor mutation in at least one of the 
genes encoding desmosomal proteins expressed in the heart: PG (JUP), plakophilin2 (PKP2), 
desmoplakin (DSP), desmocollin2 (DSC2), and desmoglein2 (DSG2). Thus, AC is classified as a 
disease of the desmosome. The majority of desmosomal gene mutations (48.1%) have been 
identified in PKP2(8)  while JUP represents the least affected, contributing to 3.8% of all 
mutations(9) (see Table 1 and Fig. 1 for a summary of pathogenic JUP mutations). 
 
Prompted by the observation that since our publication 10 further mutations have been reported 
in JUP and that all of these mutations, with the except of p.Q539X which resulted in early 
lethality due to severe skin involvement (10), are associated with AC(9), we re-visited the 
hospital records of patients harboring p.S24X and the splice site mutation, c.468G>A. Informed 
consent and ethical approval to study molecular and skin pathology in these children were 
obtained for the original study(1), while here we report clinical follow-up. These five patients are 
monitored regularly (every 2-3 years) and records showed that the eldest patient harboring 
p.S24X presented with slight dilation of the left ventricle with normal systolic function as 
determined by Doppler echocardiography at age 17 (Table 2). The cardiac involvement 
progressed to diagnosis of left dilated cardiomyopathy 20 months later, age 19, at which point 
the patient was prescribed angiotensin-converting enzyme inhibitors and -blockers. Further 
monitoring will determine whether an implantable cardioverter-defibrillator (ICD) is necessary 
(11). Given the development of heart involvement we propose to reclassify patients harboring 
p.S24X mutation in JUP as a cardio-cutaneous syndrome.  
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Since our original report the two patients harboring c.468G>A mutation in JUP have two new 
siblings affected by the same disorder. All four individuals share phenotypic characteristics 
which include: diffuse hypotrichosis, diffuse palmoplantar keratoderma (observed to worsen 
with advancing age), recurrent paronychia followed by nail-dystrophy; skin fragility; eczematoid 
skin rashes affecting mainly the scalp, face & extremities; poor dentition; and recurrent skin 
infections. As previously reported the most notable difference with patients harboring p.S24X 
JUP mutation is the presence of hypotrichosis (1) (Figure 2). Given the structural and 
ultrastructural similarities we previously reported between patients harboring homozygous 
p.S24X and c.468G>A mutations(1), we predict that patients with c.468G>A will likely develop 
similar cardiac abnormalities. All patients will continue to be monitored on a regular basis. 
 
REFERENCES 
1. Cabral RM, Liu L, Hogan C, Dopping-Hepenstal PJ, Winik BC, Asial RA, et al. Homozygous 
mutations in the 5' region of the JUP gene result in cutaneous disease but normal heart development in 
children. J Invest Dermatol. 2010 Jun;130(6):1543-50. 
2. Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, McKenna WJ. A novel dominant 
mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 
2007 Nov;81(5):964-73. 
3. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, et al. 
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with 
palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000 Jun 17;355(9221):2119-24. 
4. Ly S, Marcus FI, Xu T, Towbin JA. A woman with incidental findings of ventricular aneurysms 
and a desmosomal cardiomyopathy. Heart Rhythm. 2008 Oct;5(10):1455-7. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
5. Swope D, Li J, Radice GL. Beyond cell adhesion: the role of armadillo proteins in the heart. Cell 
Signal. 2013 Jan;25(1):93-100. 
6. Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Common J, Purkis PE, et al. Recessive 
mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated 
cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet. 2000 Nov 1;9(18):2761-6. 
7. Basso C, Bauce B, Corrado D, Thiene G. Pathophysiology of arrhythmogenic cardiomyopathy. 
Nat Rev Cardiol. 2012 Apr;9(4):223-33. 
8. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, et al. Mutations in the 
desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat 
Genet. 2004 Nov;36(11):1162-4. 
9. Lazzarini E, Jongbloed JD, Pilichou K, Thiene G, Basso C, Bikker H, et al. The ARVD/C genetic 
variants database: 2014 update. Hum Mutat. 2015 Apr;36(4):403-10. 
10. Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podda M, et al. Lack of plakoglobin 
leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet. 2011 
May 1;20(9):1811-9. 
11. Tichnell C, James CA, Murray B, Tandri H, Sears SF, Calkins H. Cardiology patient page. 
Patient's guide to arrhythmogenic right ventricular dysplasia/cardiomyopathy: past to present. Circulation. 
2014 Sep 2;130(10):e89-92. 
12. den Haan AD, Tan BY, Zikusoka MN, Llado LI, Jain R, Daly A, et al. Comprehensive 
desmosome mutation analysis in north americans with arrhythmogenic right ventricular 
dysplasia/cardiomyopathy. Circ Cardiovasc Genet. 2009 Oct;2(5):428-35. 
13. Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, et al. Compound and digenic 
heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010 
Feb 9;55(6):587-97. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
14. Christensen AH, Benn M, Bundgaard H, Tybjaerg-Hansen A, Haunso S, Svendsen JH. Wide 
spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular 
cardiomyopathy. J Med Genet. 2010 Nov;47(11):736-44. 
15. Erken H, Yariz KO, Duman D, Kaya CT, Sayin T, Heper AO, et al. Cardiomyopathy with 
alopecia and palmoplantar keratoderma (CAPK) is caused by a JUP mutation. Br J Dermatol. 2011 
Oct;165(4):917-21. 
16. Bao J, Wang J, Yao Y, Wang Y, Fan X, Sun K, et al. Correlation of ventricular arrhythmias with 
genotype in arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2013 
Dec;6(6):552-6. 
17. Exome Aggregation Consortium, Lek M, Karczewski K, Minikel E, Samocha K, Banks E, et al., 
Analysis of protein-coding genetic variation in 60,706 humans. bioRxiv doi: 
http://dx.doi.org/10.1101/030338 
 
Table 1: Spectrum of JUP mutations, phenotype, mode of inheritance, and allele frequency 
identified in the Exome Aggregation Consortium (ExAC) database (accessed January 1
st
 
2016). The ExAC database reports exome sequencing data from >60,000 unrelated individuals 
and indicates the prevalence of previously reported pathogenic JUP mutations. D = dominant, R 
= recessive. * - homozygous mutation, p.Q529X resulted in post-natal lethality due to massive 
transcutaneous fluid loss with apparent normal heart development (10). ** - p.V603L identified 
in one family with incomplete penetrance (14). 
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Mutation Reference Phenotype Inheritance Allele Count Allele Frequency 
p.T19I 12 Heart D 13 0.0001139 
p.S24X 1 
Skin and 
Heart R - - 
p.S39_K40insS 2 Heart D - - 
p.I131del 13 Heart D - - 
c.468G>A 1 
Skin (eldest 
9 yrs) R - - 
p.V159L 4, 13 Heart D 5 0.00004237 
p.S225L 14 Heart D 1 0.000008256 
p.R265H 15 
Skin and 
Heart R 1 0.000008252 
p.E301G 9 
Skin and 
Heart R 1 0.000008256 
p.V407I 14 Heart D 3 0.00002472 
p.T427M 14, 16 Heart D 6 0.0000494 
p.Q529X 10 Skin (lethal)* R - - 
p.V603L 14 Heart D** 76 0.0006604 
p.G680fsX690 3 
Skin and 
Heart R - - 
p.Y693C 16 Heart D 3 0.00002563 
 
Table 2: Cardiac investigations in patients with homozygous JUP mutations, p.S24X or 
c.468G>A. 
Patient  Mutation Age of cardiac investigation and result  
1 p.S24X 16 years, normal 
2 p.S24X  17 years, Left Dilated Cardiomyopathy 
3 p.S24X  9 years, normal 
4 c.468G>A 9 years, normal 
5 c.468G>A 7 years, normal  
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FIGURE LEGEND 
Fig. 1: 15 pathogenic variants have been identified in JUP encoding plakoglobin. Cartoon 
shows plakoglobin protein and the relative locations of pathogenic mutations identified to date. 
Blue text indicates mutations resulting in cardiomyopathy only while red text indicates skin 
involvement, with lighter red indicating no reported cardiomyopathy. Boxes represent Armadillo 
repeat domains.  
 
Fig. 2: Patients harboring homozygous p.S24X JUP mutations do not exhibit hypotrichosis 
as observed in c.468G>A homozygous patients. 
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